Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (24)
  • 2024 (29)
  • 2023 (54)
  • 2022 (90)
  • 2021 (71)
  • 2020 (10)
  • 2019 (6)
  • 2018 (2)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Press Conferences (68)

Drug Name

  • Fentanyl (64)
  • Opioids (51)
  • Oxycodone (49)
  • Cocaine (23)
  • Methamphetamine (19)
  • Synthetic Opioids (17)
  • Heroin (13)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Marijuana (Cannabis) (2)
  • Ecstasy/MDMA (1)
  • GHB (1)

Field Division

  • Washington, DC (55)
  • St. Louis (33)
  • New York (23)
  • Chicago (20)
  • Sede (18)
  • New Jersey (17)
  • Miami (16)
  • El Paso (13)
  • Atlanta (12)
  • Seattle (12)
  • Dallas (11)
  • Houston (9)
  • Rocky Mountain (7)
  • San Francisco (7)
  • New England (6)
  • New Orleans (6)
  • Los Angeles (5)
  • Louisville (5)
  • Omaha (5)
  • San Diego (5)
  • Phoenix (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

North Carolina Pharmacy Agrees to Pay $100,000 Fine

Febrero 03, 2022
DURHAM, N.C. – Aspirar Pharmacy, LLC and Aspirar Pharmacy of Durham, LLC (collectively Aspirar Pharmacy), located in Cary and Durham, North Carolina, respectively, have agreed to pay the United States $100,000 to resolve allegations that they violated the Controlled Substances Act from 2017-2018 by filling prescriptions for a physician who...
Febrero 03, 2022
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

Febrero 02, 2022
NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...
Febrero 02, 2022
PRESS RELEASE

Florida-Based Pharmaceutical President Indicted in Counterfeit Promethazine-Codeine Drug Trafficking Conspiracy

Febrero 02, 2022
BEAUMONT, Texas – A federal grand jury in Beaumont has returned a three-count indictment charging a Florida resident, along with nine other individuals, in a drug trafficking conspiracy in the Eastern District of Texas, announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S...
Febrero 02, 2022
PRESS RELEASE

Ready Pharmacy agrees to $400,000 settlement relating to Controlled Substances Act claims

Febrero 01, 2022
ALBUQERQUE, N.M. – Fred J. Federici, U.S. Attorney for the District of New Mexico, has announced that Ready Pharmacy has agreed to a $400,000 settlement relating to civil claims brought by the Department of Justice on behalf of the U.S. Drug Enforcement Administration’s (DEA) El Paso Division Regulatory Diversion Group...
Febrero 01, 2022
PRESS RELEASE

DEA Washington Holds Press Conference with D.C. Partners on Overdose Deaths in the District

Enero 31, 2022
Washington, D.C. -- Today, after significant arrests in the case, DEA Washington Division SAC Jarod Forget and D.C. Metropolitan Police (MPD) Chief Robert J. Contee III of the Metropolitan Police Department hosted a press conference on the recent string of fatal drug overdoses in the Nation’s Capital. SAC Jarod Forget...
Enero 31, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
PRESS RELEASE

Law Enforcement Partnership in Nebraska Takes Stance Against Methamphetamine

Enero 26, 2022
KEARNEY, Neb. – In response to the increasing amount of methamphetamine seen threatening Nebraskans, federal, state and local law enforcement agencies in Nebraska have formed a coalition to help combat the number one drug threat in both rural and urban communities across the state. Nebraska Attorney General, Doug Peterson; Interim...
Enero 26, 2022
PRESS RELEASE

Twenty Charged in ‘Operation Shut Down Corner’

Enero 26, 2022
Dallas - Twenty alleged drug dealers and their associates have been arrested and charged in “Operation Shut Down Corner,” announced DEA Special Agent in Charge Eduardo A. Chávez. The operation – which involved more than 150 agents and officers from the North Texas OCEDTF Strike Force – focused on Hamilton...
Enero 26, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

Enero 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man, and former veterinarian, pleaded guilty to a pair of drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to the adulteration of a drug held...
Enero 24, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

Enero 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
Enero 24, 2022
Showing 181 - 190 of 289 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 15
  • Página 16
  • Página 17
  • Página 18
  • Current page 19
  • Página 20
  • Página 21
  • Página 22
  • Página 23
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster